U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Multicentric Cutaneous Involvement

MedGen UID:
307860
•Concept ID:
C1513733
•
Finding

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVMulticentric Cutaneous Involvement

Professional guidelines

PubMed

Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients.
Cohen E, Lheure C, Ingen-Housz-Oro S, Hotz C, Bettuzzi T, Chasset F, Descamps V, Deschamps L, Mahevas M, Terrier B, Sohier P, Guegan S, Kramkimel N, Darbord D, Chanal J, Oulès B, Aractingi S, Seta V, Dupin N
Eur J Dermatol 2023 Dec 1;33(6):680-685. doi: 10.1684/ejd.2023.4584. PMID: 38465550
Surgical Treatment of Camptodactyly with Malek Cutaneous Approach and Stepwise Release: A Retrospective Multi-centre Study.
Corain M, Lando M, Pantaleoni F, Pozza P, Giardini M, Adani R
J Hand Surg Asian Pac Vol 2022 Apr;27(2):233-241. Epub 2022 Mar 31 doi: 10.1142/S2424835522500308. PMID: 35404199
Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study.
Brüggen MC, Valencak J, Stranzenbach R, Li N, Stadler R, Jonak C, Bauer W, Porkert S, Blaschke A, Meiss F, Nicolay JP, Wehkamp U, Schlaak M, Nguyen VA, Romani N, Cozzio A, Gayathri N, Dimitriou F, French LE, Dummer R, Guenova E
J Eur Acad Dermatol Venereol 2020 Jul;34(7):1489-1495. Epub 2020 Mar 10 doi: 10.1111/jdv.16215. PMID: 31955469

Recent clinical studies

Etiology

Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study.
Kawsar A, Edwards C, Patel P, Heywood RM, Gupta A, Mann J, Harland C, Heelan K, Larkin J, Lorigan P, Harwood CA, Matin RN, Fearfield L
Br J Dermatol 2022 Dec;187(6):981-987. Epub 2022 Sep 6 doi: 10.1111/bjd.21836. PMID: 35976170
Interventions for cutaneous disease in systemic lupus erythematosus.
Hannon CW, McCourt C, Lima HC, Chen S, Bennett C
Cochrane Database Syst Rev 2021 Mar 9;3(3):CD007478. doi: 10.1002/14651858.CD007478.pub2. PMID: 33687069Free PMC Article
Cutaneous paraneoplastic syndromes.
Wick MR, Patterson JW
Semin Diagn Pathol 2019 Jul;36(4):211-228. Epub 2019 Jan 31 doi: 10.1053/j.semdp.2019.01.001. PMID: 30736994
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.
Planchard D, Besse B, Groen HJM, Souquet PJ, Quoix E, Baik CS, Barlesi F, Kim TM, Mazieres J, Novello S, Rigas JR, Upalawanna A, D'Amelio AM Jr, Zhang P, Mookerjee B, Johnson BE
Lancet Oncol 2016 Jul;17(7):984-993. Epub 2016 Jun 6 doi: 10.1016/S1470-2045(16)30146-2. PMID: 27283860Free PMC Article
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC; RegiSCAR study group
Br J Dermatol 2013 Nov;169(5):1071-80. doi: 10.1111/bjd.12501. PMID: 23855313

Diagnosis

Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study.
Kawsar A, Edwards C, Patel P, Heywood RM, Gupta A, Mann J, Harland C, Heelan K, Larkin J, Lorigan P, Harwood CA, Matin RN, Fearfield L
Br J Dermatol 2022 Dec;187(6):981-987. Epub 2022 Sep 6 doi: 10.1111/bjd.21836. PMID: 35976170
Interventions for cutaneous disease in systemic lupus erythematosus.
Hannon CW, McCourt C, Lima HC, Chen S, Bennett C
Cochrane Database Syst Rev 2021 Mar 9;3(3):CD007478. doi: 10.1002/14651858.CD007478.pub2. PMID: 33687069Free PMC Article
Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa.
El Hachem M, Zambruno G, Bourdon-Lanoy E, Ciasulli A, Buisson C, Hadj-Rabia S, Diociaiuti A, Gouveia CF, Hernández-Martín A, de Lucas Laguna R, Dolenc-Voljč M, Tadini G, Salvatori G, De Ranieri C, Leclerc-Mercier S, Bodemer C
Orphanet J Rare Dis 2014 May 20;9:76. doi: 10.1186/1750-1172-9-76. PMID: 24884811Free PMC Article
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC; RegiSCAR study group
Br J Dermatol 2013 Nov;169(5):1071-80. doi: 10.1111/bjd.12501. PMID: 23855313
Skin disorders with arthritis.
Levin J, Werth VP
Best Pract Res Clin Rheumatol 2006 Aug;20(4):809-26. doi: 10.1016/j.berh.2006.05.001. PMID: 16979539

Therapy

Infantile Myofibromatosis With Cutaneous, Visceral, and CNS Involvement: A Multimodal Approach to Therapy.
Gehle S, Quinsey C, McShane D, Thompson P, Quezada G
J Pediatr Hematol Oncol 2023 Oct 1;45(7):e921-e923. Epub 2023 Jul 13 doi: 10.1097/MPH.0000000000002717. PMID: 37526359
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study.
Nicolay JP, Melchers S, Albrecht JD, Assaf C, Dippel E, Stadler R, Wehkamp U, Wobser M, Zhao J, Burghaus I, Schneider S, Gülow K, Goerdt S, Schürch CM, Utikal JS, Krammer PH
Blood 2023 Aug 31;142(9):794-805. doi: 10.1182/blood.2022018669. PMID: 37217183Free PMC Article
Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study.
Kawsar A, Edwards C, Patel P, Heywood RM, Gupta A, Mann J, Harland C, Heelan K, Larkin J, Lorigan P, Harwood CA, Matin RN, Fearfield L
Br J Dermatol 2022 Dec;187(6):981-987. Epub 2022 Sep 6 doi: 10.1111/bjd.21836. PMID: 35976170
Interventions for cutaneous disease in systemic lupus erythematosus.
Hannon CW, McCourt C, Lima HC, Chen S, Bennett C
Cochrane Database Syst Rev 2021 Mar 9;3(3):CD007478. doi: 10.1002/14651858.CD007478.pub2. PMID: 33687069Free PMC Article
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.
Planchard D, Besse B, Groen HJM, Souquet PJ, Quoix E, Baik CS, Barlesi F, Kim TM, Mazieres J, Novello S, Rigas JR, Upalawanna A, D'Amelio AM Jr, Zhang P, Mookerjee B, Johnson BE
Lancet Oncol 2016 Jul;17(7):984-993. Epub 2016 Jun 6 doi: 10.1016/S1470-2045(16)30146-2. PMID: 27283860Free PMC Article

Prognosis

Infantile Myofibromatosis With Cutaneous, Visceral, and CNS Involvement: A Multimodal Approach to Therapy.
Gehle S, Quinsey C, McShane D, Thompson P, Quezada G
J Pediatr Hematol Oncol 2023 Oct 1;45(7):e921-e923. Epub 2023 Jul 13 doi: 10.1097/MPH.0000000000002717. PMID: 37526359
Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma.
Li SC, Higgins GC, Chen M, Torok KS, Rabinovich CE, Stewart K, Laxer RM, Pope E, Haines KA, Punaro M, O'Neil KM; Childhood Arthritis and Rheumatology Research Alliance Localized Scleroderma Clinical and Ultrasound Study group
Rheumatology (Oxford) 2021 Dec 1;60(12):5724-5733. doi: 10.1093/rheumatology/keab238. PMID: 33711155
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.
Planchard D, Besse B, Groen HJM, Souquet PJ, Quoix E, Baik CS, Barlesi F, Kim TM, Mazieres J, Novello S, Rigas JR, Upalawanna A, D'Amelio AM Jr, Zhang P, Mookerjee B, Johnson BE
Lancet Oncol 2016 Jul;17(7):984-993. Epub 2016 Jun 6 doi: 10.1016/S1470-2045(16)30146-2. PMID: 27283860Free PMC Article
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC; RegiSCAR study group
Br J Dermatol 2013 Nov;169(5):1071-80. doi: 10.1111/bjd.12501. PMID: 23855313
Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic castleman disease: review and speculations about pathogenesis.
Haque M, Hou JS, Hisamichi K, Tamada K, Cusack CA, Abdelmalek M, Brown RE, Vonderheid EC
Clin Lymphoma Myeloma Leuk 2011 Dec;11(6):453-61. Epub 2011 Sep 21 doi: 10.1016/j.clml.2011.07.004. PMID: 21940235

Clinical prediction guides

Infantile Myofibromatosis With Cutaneous, Visceral, and CNS Involvement: A Multimodal Approach to Therapy.
Gehle S, Quinsey C, McShane D, Thompson P, Quezada G
J Pediatr Hematol Oncol 2023 Oct 1;45(7):e921-e923. Epub 2023 Jul 13 doi: 10.1097/MPH.0000000000002717. PMID: 37526359
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study.
Nicolay JP, Melchers S, Albrecht JD, Assaf C, Dippel E, Stadler R, Wehkamp U, Wobser M, Zhao J, Burghaus I, Schneider S, Gülow K, Goerdt S, Schürch CM, Utikal JS, Krammer PH
Blood 2023 Aug 31;142(9):794-805. doi: 10.1182/blood.2022018669. PMID: 37217183Free PMC Article
Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study.
Kawsar A, Edwards C, Patel P, Heywood RM, Gupta A, Mann J, Harland C, Heelan K, Larkin J, Lorigan P, Harwood CA, Matin RN, Fearfield L
Br J Dermatol 2022 Dec;187(6):981-987. Epub 2022 Sep 6 doi: 10.1111/bjd.21836. PMID: 35976170
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.
Planchard D, Besse B, Groen HJM, Souquet PJ, Quoix E, Baik CS, Barlesi F, Kim TM, Mazieres J, Novello S, Rigas JR, Upalawanna A, D'Amelio AM Jr, Zhang P, Mookerjee B, Johnson BE
Lancet Oncol 2016 Jul;17(7):984-993. Epub 2016 Jun 6 doi: 10.1016/S1470-2045(16)30146-2. PMID: 27283860Free PMC Article
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC; RegiSCAR study group
Br J Dermatol 2013 Nov;169(5):1071-80. doi: 10.1111/bjd.12501. PMID: 23855313

Recent systematic reviews

Interventions for cutaneous disease in systemic lupus erythematosus.
Hannon CW, McCourt C, Lima HC, Chen S, Bennett C
Cochrane Database Syst Rev 2021 Mar 9;3(3):CD007478. doi: 10.1002/14651858.CD007478.pub2. PMID: 33687069Free PMC Article
Vipera snakebite in Europe: a systematic review of a neglected disease.
Paolino G, Di Nicola MR, Pontara A, Didona D, Moliterni E, Mercuri SR, Grano M, Borgianni N, Kumar R, Pampena R
J Eur Acad Dermatol Venereol 2020 Oct;34(10):2247-2260. Epub 2020 Jul 20 doi: 10.1111/jdv.16722. PMID: 32530549
Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.
Montero N, Favà A, Rodriguez E, Barrios C, Cruzado JM, Pascual J, Soler MJ
Cochrane Database Syst Rev 2018 May 7;5(5):CD011403. doi: 10.1002/14651858.CD011403.pub2. PMID: 29734473Free PMC Article
Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy.
Yong SM, Dublin N, Pickard R, Cody DJ, Neal DE, N'Dow J
Cochrane Database Syst Rev 2003;(1):CD003306. doi: 10.1002/14651858.CD003306. PMID: 12535469

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...